About Deep End Partners
Deep End Partners is a venture capital firm founded in 2020. It is primarily based out of New York City, United States. As of Dec 2021, Deep End Partners has invested in 6 companies. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Seed round of Maya Overall, Deep End Partners portfolio has seen 1 acquisition, namely AtaiBeckley. A lot of funds co-invest with Deep End Partners, with names like The Conscious Fund sharing a substantial percentage of its portfolio. Deep End Partners has team of 1 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed
Portfolio Acquisitions
Deep End Partners' List of Top Investments
Deep End Partners has a portfolio of 6 companies. Their most notable investments include Bexson Biomedical and AtaiBeckley.Their portfolio spans across and United States. They have invested in Life Sciences, Enterprise Applications, HealthTech and 1 other sectors, across stages such as Seed stage. Here is the list of top investments by Deep End Partners:
BEXSON is a developer of ketamine therapies for chronic and acute pain disorders. It has developed treatment solutions that can offer a real alternative to opioid-based pain management.
Key facts about Bexson Biomedical
- Founded Year: 2017
- Location: Santa Barbara (United States)
- Stage: Series A
- Total Funding till date: $4.8M
- Employee Count: 7 as on Aug 31, 2026
- Investors: Palo Santo, Noetic Psychedelic Fund and 6 Others
- Latest Funding Round: Series A, Feb 02, 2021, $*****
- Highlight: Editors' Pick
2. AtaiBeckley
Developer of therapies intended to transform mental health treatment options. The company focuses on creating effective, rapid-acting, and convenient treatments. It aims to address the unmet needs in mental health by developing patient-first, evidence-based therapies. The company's team consists of drug development, healthcare, and commercialization experts.
Key facts about AtaiBeckley
- Founded Year: 2025
- Location: New York City (United States)
- Annual Revenue: $0 - $1M as on Dec 31, 2024
- Stage: Acquired
- Employee Count: 106 as on Sep 30, 2026
- Investors: Bright Success Capital, Cavendish Privateers and 35 Others
- Highlight: Acquired
3. Maya
Provider of AI automation systems for healthcare and financial sectors. The company delivers solutions for psychiatric research, life sciences, concierge medicine, and payments. It offers automations for customer support, churn prediction, talent recruitment, and sales pipeline management. The company focuses on data security, compliance, and ethical AI development. It provides implementation, integration, optimization, and support services.
Key facts about Maya
- Founded Year: 2019
- Location: Denver (United States)
- Stage: Seed
- Total Funding till date: $6.4M
- Employee Count: 10 as on May 31, 2026
- Investors: Innovating Capital, Explorer Equity Group and 15 Others
- Latest Funding Round: Seed, Dec 17, 2021, $*****
- Highlight: Editors' Pick
Developer of therapeutics and technologies for neurological and psychiatric diseases. The company's pipeline features assets like TerXT (xanomeline-trospium prodrugs), Idazoxan XR (alpha-2 antagonist), and selective serotonin 2A antagonists, alongside a broad psychedelics program with prodrugs and psychoplastogens. They also lead in AI-enabled software, with NM-101 as the first FDA-cleared tool for neuromelanin MRI analysis, aiding diagnosis via dopamine/norepinephrine neuron biomarkers.
Key facts about Terran Biosciences
- Founded Year: 2019
- Location: United States
- Stage: Funding Raised
- Employee Count: 4 as on Aug 31, 2026
- Investors: AA Sons, Transhuman Capital and 9 Others
- Highlight: Editors' Pick
5. DoubleBlind
Provider of print magazine and digital media services. This organization publishes articles, research summaries, and instructional guides focused on mycology, pharmacology, and cultural developments related to psychoactive compounds. It offers online courses covering cultivation techniques, integration practices, and safety protocols for individuals interested in the field. The materials address scientific findings, regulatory updates, and historical perspectives on the use of these substances.
Key facts about DoubleBlind
- Founded Year: 2019
- Location: Los Angeles (United States)
- Stage: Funding Raised
- Employee Count: 14 as on Aug 31, 2026
- Investors: Palo Santo, UMANA House of Funds and 4 Others
Deep End Partners' Year-on-Year Investment Trends
Deep End Partners has invested in 6 companies over the last 5 years, with an average of 0 new investment annually in the last 5 years. Its most recent first time investment was in Maya.Deep End Partners' Investments by Stage
Deep End Partners has made 1 investment in Seed stage with an average round size of $4.3M.Deep End Partners' Investments by Sector
Deep End Partners has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech and Vertical SaaS. Notably, it has invested in 4 Enterprise (B2B) companies, 4 Tech companies, 3 Consumer (B2C) companies and at least 1 company focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 1 |
HealthTech | 1 |
Vertical SaaS | 1 |
Note: We have considered here, only first round of investments
Deep End Partners' Investments by Geography
Deep End Partners has made most investments in United States (1).Deep End Partners' recent investments
Deep End Partners has not made any investment in 2026 so far.Here are the most recent investments by Deep End Partners:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 17, 2021 | United States | Seed | 2111 | [+12] |
Acquired companies in Deep End Partners' Portfolio
1 company from Deep End Partners' portfolio has been acquired. The most recent acquisition was AtaiBeckley in Jul 2026 by Lilly for $*****.Here are Deep End Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 16, 2026 | - | - | 6825 |
Team profile of Deep End Partners
Deep End Partners has a team of 1 member located in United States. Deep End Partners' team does not sit on the board of any company as of now.Co-investors of Deep End Partners
Over the past 5 years, 13 investors have co-invested in Deep End Partners's portfolio companies. This includes funds and angels.
- Top Co-investors of Deep End Partners: 13 investors entered a company along with Deep End Partners. These include investors like The Conscious Fund (1 company).
Recent News related to Deep End Partners
•
Maya Health Raises $4.3 Million to Decentralize Psychedelic Medicine ResearchPRWeb•Dec 17, 2021•Maya, The Conscious Fund, Deep End Partners, The BWC Group and 3 others
